Table 2.
Cancer specific survival | Overall survival | |
---|---|---|
Histology | ||
Endometrioid | Referent | Referent |
Mucinous | 0.90 (0.74-1.09) | 0.95 (0.85-1.07) |
Age | ||
<60 years | Referent | Referent |
>60 years | 1.80 (1.66-1.96)* | 2.85 (2.69-3.03)* |
Race | ||
White | Referent | Referent |
Black | 1.39 (1.22-1.59)* | 1.29 (1.18-1.42)* |
Other | 1.04 (0.89-1.22) | 0.89 (0.80-1.01) |
Unknown | 0.28 (0.07-1.11) | 0.60 (0.32-1.11) |
Year of diagnosis | ||
1988-1994 | Referent | Referent |
1995-2000 | 0.99 (0.87-1.12) | 1.01 (0.93-1.09) |
2001-2006 | 0.98 (0.86-1.11) | 0.98 (0.90-1.06) |
Marital status | ||
Married | Referent | Referent |
Single | 1.24 (1.15-1.34)* | 1.48 (1.41-1.55)* |
Unknown | 0.99 (0.80-1.23) | 1.19 (1.05-1.36)* |
SEER registry | ||
Eastern | Referent | Referent |
Central | 1.09 (0.99-1.20) | 1.09 (1.02-1.16)* |
Western | 0.98 (0.90-1.07) | 0.95 (0.90-1.01) |
Grade | ||
1 | Referent | Referent |
2 | 2.08 (1.86-2.32)* | 1.38 (1.29-1.46)* |
3 | 4.66 (4.16-5.22)* | 2.56 (2.39-2.73)* |
Unknown | 2.52 (2.14-2.98)* | 1.58 (1.42-1.75)* |
Stage | ||
IA | Referent | Referent |
IB | 2.14 (1.88-2.44)* | 1.72 (1.60-1.86)* |
I-II NOS | 2.45 (2.14-2.79)* | 1.61 (1.49-1.74)* |
II | 3.14 (2.53-3.90)* | 2.15 (1.86-2.49)* |
III | 8.28 (7.43-9.24)* | 3.95 (3.67-4.26)* |
IV | 20.77 (18.54-23.27)* | 8.34 (7.67-9.06)* |
Unknown | 5.34 (4.45-6.41)* | 2.44 (2.12-2.81)* |
Lymphadenectomy | ||
No (0) | Referent | Referent |
Yes (1) | 0.71 (0.66-0.77)* | 0.72 (0.68-0.76)* |
P<0.05